OLPX / Olaplex Holdings, Inc. - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2025 Olaplex Holdings,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission

Certain confidential information contained in this document, marked by “[***]”, has been omitted because it is both not material and would be competitively harmful if publicly disclosed.

EX-2.1 Certain confidential information contained in this document, marked by “[***]”, has been omitted because it is both not material and would be competitively harmful if publicly disclosed. Exhibit 2.1 Execution Version CONFIDENTIAL STOCK PURCHASE AGREEMENT among OLAPLEX, INC., as the Buyer, PURVALA BIOSCIENCE, INC., as the Company, THE STOCKHOLDERS AND OPTIONHOLDERS OF THE COMPANY, as the For

OLAPLEX Acquires Biotech Company Purvala Ten years after launch, OLAPLEX’s first acquisition demonstrates its commitment to product innovation

EX-99.1 Exhibit 99.1 OLAPLEX Acquires Biotech Company Purvala Ten years after launch, OLAPLEX’s first acquisition demonstrates its commitment to product innovation NEW YORK, NY, August 26, 2025 – Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”) today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX sinc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001

OLAPLEX Reports Second Quarter 2025 Results

Exhibit 99.1 OLAPLEX Reports Second Quarter 2025 Results NEW YORK, NY – August 7, 2025 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the second quarter ended June 30, 2025. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "We delivered a solid first half of 2025. We remain in the midst of a multi-pronged transformation and a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Olaplex Holdings,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission F

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission File

OLAPLEX Reports First Quarter 2025 Results

Exhibit 99.1 OLAPLEX Reports First Quarter 2025 Results NEW YORK, NY – May 8, 2025 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the first quarter ended March 31, 2025. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "We had a solid start to the year as the quarter marked continued progress on our transformation and our Bon

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2025 Olaplex Holdings,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ De

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ De

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission F

, by and between Olaplex, Inc. and

Exhibit 10.22 1187 Coast Village Road #1-520 Santa Barbara, CA 93108 April 17, 2023 Trisha Fox Dear Trisha, I am pleased to offer you employment with Olaplex, Inc. (the “Company”) in the position of Chief People Officer, reporting to JuE Wong, CEO, subject to the terms and conditions described in this letter. If you accept this conditional offer, your first date of employment with the Company is a

, by and between Olaplex, Inc. and

Exhibit 10.21 1187 Coast Village Road #1-520 I Santa Barbara, CA 93108 February 17, 2022 Dear John: I am pleased to offer you employment with Olaplex, Inc. (the "Company") in the position of General Counsel reporting to the CEO. If you accept this offer, your first date of employment with the Company will be tbd. Your initial salary will be at the rate of $400,000.00 per year, less taxes and other

Olaplex Holdings, Inc. Insider Trading Policy.

Exhibit 19 OLAPLEX HOLDINGS, INC. INSIDER TRADING POLICY 1.Purpose. This Insider Trading Policy (this “Policy”) provides guidelines with respect to transactions in the securities of Olaplex Holdings, Inc. (the “Company”) and the handling of Company confidential information. The Company’s Board of Directors (the “Board”) has adopted this Policy to promote compliance with U.S. federal and state secu

OLAPLEX Reports Fourth Quarter and Fiscal Year 2024 Results

Exhibit 99.1 OLAPLEX Reports Fourth Quarter and Fiscal Year 2024 Results NEW YORK, NY – March 4, 2025 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2024. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "I am pleased with our end to the year with our fourth quarter result

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Olaplex Intermediate, Inc. Olaplex Intermediate II, Inc. Penelope Holdings Corp. Penelope Intermediate Corp. Olaplex, Inc. Olaplex UK Limited Delaware Delaware Delaware Delaware Delaware United Kingdom

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Olaplex Holdings, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40860 Olaplex

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2025 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fi

As filed with the Securities and Exchange Commission on March 4, 2025

As filed with the Securities and Exchange Commission on March 4, 2025 Registration No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission

etter Agreement, dated July 1, 2024, by and between Olaplex, Inc. and Catherine Dun

Exhibit 10.1 1187 Coast Village Road #1-520 I Santa Barbara, CA 93108 July 1, 2024 Catherine Dunleavy, via email Dear Catherine, I am pleased to offer you employment with Olaplex, Inc. (the “Company”) in the position of Chief Operating Officer & Chief Financial Officer of the Company and Olaplex Holdings, Inc. (“Holdings”), reporting to me, subject to the terms and conditions described in this let

OLAPLEX Reports Third Quarter 2024 Results Revises Fiscal Year 2024 Guidance

Exhibit 99.1 OLAPLEX Reports Third Quarter 2024 Results Revises Fiscal Year 2024 Guidance NEW YORK, NY – November 7, 2024 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the third quarter and nine months ended September 30, 2024. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "This year has been dedicated to transformation a

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

Change Order to Engagement Letter, dated August 13, 2024, by and between Alvarez & Marsal Private Equity Performance Improvement Group, LLC and Olaplex Holdings, Inc. (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q, filed on November 7, 2024 (File No. 001-40860)).

Exhibit 10.2 Change Order #1 As of August 13, 2024 Amanda Baldwin, Chief Executive Officer Olaplex Holdings, Inc. 432 Park Ave South, 3rd Floor New York, NY 10016 Dear Amanda: This change order #1 (“Change Order #1”) documents certain changes to the engagement letter agreement between Alvarez & Marsal Private Equity Performance Improvement Group, LLC (“A&M”) and Olaplex Holdings, Inc. (the “Compan

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 23, 2024 Olaplex Holdings, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2024 Olaplex Holdings,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission

OLAPLEX Reports Second Quarter 2024 Results Reiterates Fiscal Year 2024 Guidance

Exhibit 99.1 OLAPLEX Reports Second Quarter 2024 Results Reiterates Fiscal Year 2024 Guidance NEW YORK, NY – August 6, 2024 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the second quarter and six months ended June 30, 2024. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "Our second quarter performance was in line with our

As filed with the Securities and Exchange Commission on August 6, 2024

As filed with the Securities and Exchange Commission on August 6, 2024 Registration No.

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Olaplex Holdings, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission F

Engagement Letter, dated April 3, 2024, by and between Alvarez & Marsal Private Equity Performance Improvement Group, LLC and Olaplex Holdings, Inc.

Exhibit 10.1 April 3, 2024 Olaplex Holdings, Inc. C/O Amanda Baldwin 1178 Coast Village Rd. Suite 1-520 Santa Barbara, CA 93108 Dear Amanda: This letter confirms and sets forth the terms and conditions of the engagement between Alvarez & Marsal Private Equity Performance Improvement Group, LLC (“A&M”) and Olaplex Holdings, Inc., and its assigns and successors (the “Company”), including the scope o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 11, 2024 Olaplex Holdings, Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 11, 2024 Olaplex Holdings, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 Olaplex Holdings, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fi

Certificate of Amendment to the Restated Certificate of Incorporation of Olaplex Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on June 14, 2024 (File No. 001-40860)).

CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION OF OLAPLEX HOLDINGS, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission File

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission File

OLAPLEX Reports First Quarter 2024 Results Reiterates Fiscal Year 2024 Guidance

Exhibit 99.1 OLAPLEX Reports First Quarter 2024 Results Reiterates Fiscal Year 2024 Guidance NEW YORK, NY – May 2, 2024 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the first quarter ended March 31, 2024. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "Our first quarter results represent progress on the business transform

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ De

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ De

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ De

OLAPLEX Announces CFO Transition Company Reaffirms Q1 2024 Net Sales Guidance

Exhibit 99.1 OLAPLEX Announces CFO Transition Company Reaffirms Q1 2024 Net Sales Guidance SANTA BARBARA, Calif., April 4, 2024 – Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or “the Company”) today announced that Eric Tiziani will step down as Chief Financial Officer to pursue another opportunity, effective May 3. The company has launched an external search for a new CFO in partnership with a

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 3, 2024 Olaplex Holdings, Inc.

Amended and Restated Letter Agreement, dated December 11, 2023, by and among Olaplex, Inc., Olaplex Holdings, Inc. and Amanda Baldwin.

Exhibit 10.19 December 11, 2023 Dear Amanda, I am pleased to offer you employment with Olaplex, Inc. (the “Company”) in the position of Chief Executive Officer of the Company and Olaplex Holdings, Inc. (“Holdings”), reporting exclusively to the Board of Directors of Holdings (the “Board”), on the terms and conditions described in this letter. This offer letter supersedes in its entirety the offer

Olaplex Holdings, Inc. Policy for Recoupment of Incentive Compensation

Exhibit 97 OLAPLEX HOLDINGS, INC. POLICY FOR RECOUPMENT OF INCENTIVE COMPENSATION 1.Introduction. In accordance with Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the regulations thereunder, the Board of Directors (the “Board”) of Olaplex Holdings, Inc. (the “Company”) has adopted this policy (the “Policy”) providing for the Company’s recoupment of certai

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Olaplex Intermediate, Inc. Olaplex Intermediate II, Inc. Penelope Holdings Corp. Penelope Intermediate Corp. Olaplex, Inc. Olaplex UK Limited Delaware Delaware Delaware Delaware Delaware United Kingdom

OLAPLEX Reports Fourth Quarter and Fiscal Year 2023 Results

Exhibit 99.1 OLAPLEX Reports Fourth Quarter and Fiscal Year 2023 Results SANTA BARBARA, California – February 29, 2024 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. For the fourth quarter 2023 compared to the fourth quarter 2022: •Net sales decreased 14.5% to $111.7 million; ◦Ne

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40860 Olaplex

Transition and Separation Agreement, dated October 10, 2023, by and between Olaplex, Inc. and JuE Wong.

Exhibit 10.18 October 10, 2023 JuE Wong Dear JuE: The purpose of this letter agreement (this “Agreement”) is to confirm the terms of the remainder of your employment with Olaplex, Inc. (the “Company”) and your separation from the Company, as follows. Capitalized words that are used but not defined herein shall have the meanings ascribed to such terms in the Termination Protection Agreement by and

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commissio

OLPX / Olaplex Holdings, Inc. / ADVENT INTERNATIONAL CORP/MA - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Olaplex Holdings, Inc. (Name of Issuer) COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 679369108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commissio

OLAPLEX Reports Third Quarter 2023 Results

Exhibit 99.1 OLAPLEX Reports Third Quarter 2023 Results SANTA BARBARA, California – November 7, 2023 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company"), today announced results for the third quarter ended September 30, 2023. J.P. Bilbrey, the Company's interim Chief Executive Officer, said, "Our third quarter results and the encouraging early indicators from our increased investm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission

Amended and Restated 2020 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q, filed on November 7, 2023 (File No. 001-40860)).

Exhibit 10.2 OLAPLEX HOLDINGS, INC. AMENDED & RESTATED 2020 OMNIBUS EQUITY INCENTIVE PLAN Article 1. Establishment & Purpose 1.1 Establishment. The Penelope Holdings Corp. 2020 Omnibus Equity Incentive Plan (the “Original Plan”) was originally adopted and approved by the Board of Directors of Penelope Group Holdings GP, LLC and the Board of Directors of Penelope Holdings Corp. on January 8, 2020.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 8, 2023 Olaplex Holdings, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001

OLAPLEX Reports Second Quarter 2023 Results Revises Fiscal Year 2023 Guidance

Exhibit 99.1 OLAPLEX Reports Second Quarter 2023 Results Revises Fiscal Year 2023 Guidance SANTA BARBARA, California – August 8, 2023 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company"), today announced results for the second quarter ended June 30, 2023. JuE Wong, OLAPLEX’s President and Chief Executive Officer, stated: "Our second quarter performance was below our expectations as

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission F

Manufacturing and Supply Agreement, dated August 4, 2023, by and between Olaplex, Inc. and Cosway Company Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q, filed on August 8, 2023 (File No. 001-40860)).

Exhibit 10.1 MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement (“Agreement”) is made and dated this 4th day of August, 2023 by and between Olaplex, Inc. (“Olaplex” or “Customer”), a Delaware corporation with an address at 1187 Coast Village Road #1-520, Santa Barbara, CA, 93108 and Cosway Company Inc., a California corporation with an address at 20633 S. Fordyce Ave, Carso

Letter Agreement dated July 10, 2023, by and between Olaplex Holdings, Inc. and John P. Bilbrey (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on July 11, 2023 (File No. 001-40860)).

Exhibit 10.1 July 10, 2023 John P. Bilbrey Dear JP: This letter agreement (this “Agreement”) sets forth the terms and conditions of your engagement on the Board of Directors (the “Board”) of Olaplex Holdings, Inc. (the “Company”). •Duties and Obligations. It is anticipated that you will be appointed to the Board on or around July 10, 2023 (the actual date of such appointment, the “Effective Date”)

OLAPLEX APPOINTS GLOBAL CONSUMER INDUSTRY VETERAN JOHN P. BILBREY TO BOARD OF DIRECTORS Bilbrey to Serve in Newly Created Role of Executive Chair; Christine Dagousset to Continue as a Director

Exhibit 99.1 OLAPLEX APPOINTS GLOBAL CONSUMER INDUSTRY VETERAN JOHN P. BILBREY TO BOARD OF DIRECTORS Bilbrey to Serve in Newly Created Role of Executive Chair; Christine Dagousset to Continue as a Director SANTA BARBARA, Calif., July 11, 2023 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company"), today announced that it has appointed John P. "JP" Bilbrey to the Company’s Board of Di

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2023 Olaplex Holdings, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fi

, 2023, by and between Olaplex, Inc. and Cosway Company Inc.

Exhibit 10.1 June 26, 2023 VIA ELECTRONIC MAIL Cosway Company Inc. 20633 South Fordyce Avenue Carson, CA 90810 Re: Amendment to Letter Agreement Dear Cosway Legal Department, The parties hereto agree to amend the Letter Agreement (the “Letter Agreement”), dated February 22, 2023, between Olaplex, Inc. (“Olaplex”) and Cosway Company Inc. (“Cosway”), to extend the Manufacturing Services Agreement ("

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 Olaplex Holdings, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fi

OLAPLEX Reports First Quarter 2023 Results

Exhibit 99.1 OLAPLEX Reports First Quarter 2023 Results SANTA BARBARA, California – May 9, 2023 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company"), today announced net sales results in line with guidance for the first quarter ended March 31, 2023. JuE Wong, OLAPLEX’s President and Chief Executive Officer, commented: "Our first quarter results were in line with our expectations an

Form of Restricted Stock Unit Agreement (Employee) under the Olaplex Holdings, Inc. 2021 Equity Incentive Plan.

Exhibit 10.2 Name: [] Number of Restricted Stock Units: [] Date of Grant: [] Vesting Commencement Date: [] OLAPLEX HOLDINGS, INC. 2021 Equity Incentive Plan Restricted Stock Unit Agreement (Employee) This agreement (this “Agreement”) evidences an award (the “Award”) of Restricted Stock Units (“RSUs”) granted by Olaplex Holdings, Inc., a Delaware corporation (the “Company”), to the individual named

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Olaplex Holdings, Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ De

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ De

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40860 Olaplex

Offer Letter, dated May 6, 2021, by and between Olaplex, Inc. and Eric Tiziani (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K, filed on February 28, 2023 (File No. 001-40860)).

Exhibit 10.19 May 6, 2021 Dear Eric: I am pleased to offer you employment with Olaplex, Inc. (the “Company”) in the position of Chief Financial Officer reporting to the CEO. If you accept this offer, your first date of employment with the Company will be June 7, 2021. Your initial salary will be at the rate of $425,000.00 per year, less taxes and other legally required deductions, payable in accor

Letter Agreement, dated December 23, 2022, by and between Olaplex Inc. and Cosway Company Inc.

Exhibit 10.6 December 23, 2022 VIA ELECTRONIC MAIL Cosway Company Inc. 20633 South Fordyce Avenue Carson, CA 90810 Re: Extension of Manufacturing Services Agreement Dear Cosway Legal Department, Notwithstanding Olaplex Inc.’s (“Olaplex”) prior written notice terminating the Manufacturing Services Agreement ("Agreement") between Olaplex and Cosway Company Inc. ("Cosway") dated January 1, 2020, the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Olaplex Holding

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commissio

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Olaplex Intermediate, Inc. Olaplex Intermediate II, Inc. Penelope Holdings Corp. Penelope Intermediate Corp. Olaplex, Inc. Olaplex UK Limited Delaware Delaware Delaware Delaware Delaware United Kingdom 1054718171

Letter Agreement, dated February 22, 2023, by and between Olaplex Inc. and Cosway Company Inc.

Exhibit 10.7 February 17, 2023 VIA ELECTRONIC MAIL Cosway Company Inc. 20633 South Fordyce Avenue Carson, CA 90810 Re: Extension of Manufacturing Services Agreement Dear Cosway Legal Department, Notwithstanding the terms of the Manufacturing Services Agreement ("Agreement") between Olaplex Inc. (“Olaplex”) and Cosway Company Inc. ("Cosway") dated January 1, 2020, and any prior agreements between O

Description of Regi

Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following summary description of the Common Stock (as defined below) of Olaplex Holdings, Inc. (the “Company”, “us”, “we”, or “our”) is based on the provisions of the Company’s restated certificate of incorporation (the “Certificate of Incorporation”) and second amend

OLAPLEX Reports Fourth Quarter and Full Year 2022 Results

Exhibit 99.1 OLAPLEX Reports Fourth Quarter and Full Year 2022 Results SANTA BARBARA, California – February 28, 2023 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2022. For fiscal year 2022 compared to fiscal year 2021: •Net sales increased 17.7% to $704.3 million; ◦Net sales increased

Second Amended and Restated Bylaws of Olaplex Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on January 20, 2023 (File No. 001-40860)).

Exhibit 3.1 SECOND AMENDED AND RESTATED BYLAWS OF OLAPLEX HOLDINGS, INC. SECTION 1—STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of Olaplex Holdings, Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shall be held

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2023 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission

OLAPLEX Reports Third Quarter 2022 Results Net Sales grew 9.2% in the third quarter 2022

Exhibit 99.1 OLAPLEX Reports Third Quarter 2022 Results Net Sales grew 9.2% in the third quarter 2022 SANTA BARBARA, California – November 9, 2022 – Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company"), today announced financial results for the third quarter and nine months ended September 30, 2022. For the third quarter of 2022 compared to the third quarter 2021: •Net sales increase

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

Amended and Restated Nonqualified Stock Option Award Agreement, effective as of December 31, 2022, by and between Olaplex Holdings, Inc. and Tiffany Walden (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q, filed on November 9, 2022 (File No. 001-40860).

Exhibit 10.2 PENELOPE HOLDINGS CORP. 2020 OMNIBUS EQUITY INCENTIVE PLAN Amended and Restated Nonqualified Stock Option Award Agreement THIS AGREEMENT (this ?Award Agreement?), originally made effective as of May 2, 2020 (the ?Grant Date?), by and between Penelope Holdings Corp., a Delaware corporation (?Holdings Corp.?) , and Tiffany Walden (the ?Participant?) is amended and restated effective as

Letter Agreement, dated October 16, 2022, by and between Olaplex Inc. and Tiffany Walden (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q, filed on November 9, 2022 (File No. 001-40860).

Exhibit 10.1 October 16, 2022 Tiffany Walden Dear Tiffany: The purpose of this letter agreement (this ?Agreement?) is to confirm (i) the terms of the remainder of your employment with Olaplex, Inc. (the ?Company?), (ii) the terms of your engagement to provide consulting services to the Company, and (iii) the rights and obligation of the parties in connection with your separation from the Company,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 Olaplex Holdings

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission

OLAPLEX Revises Fiscal 2022 Guidance Provides Preliminary Q3 2022 Sales and Net Income Expectations Company to Hold Conference Call Today at 5:00pm EST

Exhibit 99.1 OLAPLEX Revises Fiscal 2022 Guidance Provides Preliminary Q3 2022 Sales and Net Income Expectations Company to Hold Conference Call Today at 5:00pm EST SANTA BARBARA, California ? October 18, 2022 ? Olaplex Holdings, Inc. (NASDAQ: OLPX) (?OLAPLEX? or the ?Company?), today provided preliminary unaudited net sales estimates, and introduced an expected range for net income, adjusted net

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 16, 2022 Olaplex Holdings, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001

OLAPLEX Reports Second Quarter 2022 Results Net Sales grew 38.6% in the second quarter 2022 Company re-affirms fiscal year 2022 guidance

Exhibit 99.1 OLAPLEX Reports Second Quarter 2022 Results Net Sales grew 38.6% in the second quarter 2022 Company re-affirms fiscal year 2022 guidance SANTA BARBARA, California ? August 9, 2022 ? Olaplex Holdings, Inc. (NASDAQ: OLPX) (?OLAPLEX? or the ?Company?), today announced financial results for the second quarter and six months ended June 30, 2022. For the second quarter of 2022 compared to t

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2021 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incor

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2022 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 00

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2022 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fil

OLAPLEX Reports First Quarter 2022 Results Net Sales grew 58% in the first quarter 2022 Diluted EPS for the first quarter 2022 of $0.09 and Adjusted Diluted EPS of $0.13

OLAPLEX Reports First Quarter 2022 Results Net Sales grew 58% in the first quarter 2022 Diluted EPS for the first quarter 2022 of $0.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

DEF 14A 1 olaplexincproxy.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

DEFA14A 1 a2022olaplexincproxynotice.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Onl

Description of Registered Securities.

Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following summary description of the Common Stock (as defined below) of Olaplex Holdings, Inc. (the ?Company?, ?us?, ?we?, or ?our?), is based on the provisions of the Company?s restated certificate of incorporation (the ?Restated Certificate of Incorporation?) and am

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2022 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commission Fi

OLAPLEX Reports Fourth Quarter and Full-Year 2021 Results Net Sales grew 79% in the fourth quarter and 112% for the fiscal year to $598 million, exceeding guidance Diluted EPS for the fiscal year of $0.32 and Adjusted Diluted EPS of $0.40, exceeding

OLAPLEX Reports Fourth Quarter and Full-Year 2021 Results Net Sales grew 79% in the fourth quarter and 112% for the fiscal year to $598 million, exceeding guidance Diluted EPS for the fiscal year of $0.

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Subsidiaries of Olaplex Holdings, Inc. Olaplex Intermediate, Inc. Olaplex Intermediate II, Inc. Penelope Holdings Corp. Penelope Intermediate Corp. Olaplex, Inc. Olaplex UK Limited1 Delaware Delaware Delaware Delaware Delaware United Kingdom Subsidiaries of Penelope Group Holdings L.P. Penelope Holdings Corp. Penelope Intermediate Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40860 Olaplex

Credit Agreement, dated February 23, 2022, by and among Olaplex, Inc., Penelope Intermediate Corp., Goldman Sachs Bank USA, as the Administrative Agent, Swingline Lender and Issuing Bank, and the Financial Institutions party thereto as Lenders and Issuing Banks (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on February 23, 2022 (File No. 001-40860).

CREDIT AGREEMENT Dated as of February 23, 2022 among OLAPLEX, INC., as the Borrower, PENELOPE INTERMEDIATE CORP., as Holdings, THE FINANCIAL INSTITUTIONS PARTY HERETO as Lenders and Issuing Banks, and GOLDMAN SACHS BANK USA, as Administrative Agent, an Issuing Bank and the Swingline Lender GOLDMAN SACHS BANK USA, JPMORGAN CHASE BANK, N.A., MORGAN STANLEY SENIOR FUNDING, INC., BARCLAYS BANK PLC, BO

OLAPLEX Announces the Closing of New Senior Secured Credit Facilities

OLAPLEX Announces the Closing of New Senior Secured Credit Facilities SANTA BARBARA, Calif ? February 23, 2022 ? Olaplex, Inc.

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2022 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commissio

Offer Letter, dated January 28, 2022, by and between Olaplex Holdings, Inc. and Kristi Belhumeur.

1187 Coast Village Road #1-520 I Santa Barbara, CA 93108 January 28, 2022 Dear Kristi: I am pleased to offer you employment with Olaplex, Inc.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2022 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commissio

AGREEMENT OF REPORTING PERSONS

EXHIBIT 99.1 AGREEMENT OF REPORTING PERSONS Each of the undersigned hereby agrees to file jointly this Schedule to which this Agreement is attached and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934. It is understood and agreed that each of the parties hereto is responsible for the timely filing of this Schedule and any

OLPX / Olaplex Holdings Inc / ADVENT INTERNATIONAL CORP/MA - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Olaplex Holdings, Inc. (Name of Issuer) COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class of Securities) 679369108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r

OLPX / Olaplex Holdings Inc / HEILBRONN CHARLES - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

SCHEDULE 13G

CUSIP No. 679369108 SCHEDULE 13G Page 29 of 31 Pages EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned, pursuant to Rule 13d-1(k)(1) under the Act, hereby agrees and acknowledges that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of the Common Stock and the information required by this Schedul

Registration Rights Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q, filed on November 10, 2021 (File No. 001-40860)).

EXECUTION VERSION REGISTRATION RIGHTS AGREEMENT BY AND AMONG OLAPLEX HOLDINGS, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe

OLAPLEX Reports Third Quarter 2021 Results Delivers strong third quarter results Completed Initial Public Offering Company Introduces Fiscal 2021 Outlook

OLAPLEX Reports Third Quarter 2021 Results Delivers strong third quarter results Completed Initial Public Offering Company Introduces Fiscal 2021 Outlook SANTA BARBARA, California ? November 10, 2021 ? Olaplex Holdings, Inc.

Restated Certificate of Incorporation of Olaplex Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q, filed on November 10, 2021 (File No. 001- 40860)).

EX-3.1 2 ex31-restatedcertificateof.htm EX-3.1 RESTATED CERTIFICATE OF INCORPORATION OF OLAPLEX HOLDINGS, INC. Olaplex Holdings, Inc., a Delaware corporation (the “Corporation”), hereby certifies that this Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (the “DGCL”), and that: A. The name of

Amended and Restated Bylaws of Olaplex Holdings, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q, filed on November 10, 2021 (File No. 001-40860)).

AMENDED AND RESTATED BYLAWS OF OLAPLEX HOLDINGS, INC. SECTION 1 -STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of Olaplex Holdings, Inc., a Delaware corporation (the ?Corporation?), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shall be held at the place, if

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2021 Olaplex Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40860 87-1242679 (State or other jurisdiction of incorporation) (Commissio

Income Tax Receivable Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q, filed on November 10, 2021 (File No. 001-40860)).

EXECUTION VERSION INCOME TAX RECEIVABLE AGREEMENT Dated as of September 29, 2021 This INCOME TAX RECEIVABLE AGREEMENT (as amended from time to time, this ?Agreement?), dated as of September 29, 2021, is hereby entered into by and among Olaplex Holdings, Inc.

As filed with the Securities and Exchange Commission on October 4, 2021

As filed with the Securities and Exchange Commission on October 4, 2021 Registration No.

73,700,000 Shares Common Stock

Table of Contents Filed Pursuant to Rule 424(b)(4) File No. 333- 259116 73,700,000 Shares Common Stock This is an initial public offering of shares of common stock of Olaplex Holdings, Inc. All of the shares of our common stock are being offered by the selling stockholders identified in this prospectus. We will not receive any proceeds from the sale of the shares being sold by the selling stockhol

The description of the Registrant’s Common Stock, $0.001 par value per share, contained in the Registrant’s Registration Statement on Form 8-A, filed with the Commission pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on September 30, 2021, and any other amendments or reports filed for the purpose of updating such description (File No. 001-40860).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A For Registration of Certain Classes of Securities Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OLAPLEX HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 87-1242679 (State of Incorporation) (I.R.S. Employer Identification No.) Address Not Applicable1 Zip Code Not

As filed with the Securities and Exchange Commission on September 29, 2021

As filed with the Securities and Exchange Commission on September 29, 2021 Registration No.

Form of Restated Certificate of Incorporation of Olaplex Holdings, Inc.

Exhibit 3.1 RESTATED CERTIFICATE OF INCORPORATION OF OLAPLEX HOLDINGS, INC. Olaplex Holdings, Inc., a Delaware corporation (the ?Corporation?), hereby certifies that this Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (the ?DGCL?), and that: A. The name of the Corporation is: Olaplex Holdin

Form of Registration Rights Agreement.

Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT BY AND AMONG OLAPLEX HOLDINGS, INC. AND CERTAIN STOCKHOLDERS DATED AS OF [ ], 2021 TABLE OF CONTENTS ARTICLE I EFFECTIVENESS 1 Section 1.1. Effectiveness. 1 ARTICLE II DEFINITIONS 1 Section 2.1. Definitions. 1 Section 2.2. Other Interpretive Provisions. 5 ARTICLE III REGISTRATION RIGHTS 6 Section 3.1. Demand Registration. 6 Section 3.2. Shelf Registration

As filed with the Securities and Exchange Commission on September 28, 2021.

Table of Contents As filed with the Securities and Exchange Commission on September 28, 2021.

Olaplex Holdings, Inc. 1187 Coast Village Rd, Suite 1-520 Santa Barbara, CA 93108

Olaplex Holdings, Inc. 1187 Coast Village Rd, Suite 1-520 Santa Barbara, CA 93108 September 27, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Dillon Hagius Re: Olaplex Holdings, Inc. Registration Statement on Form S-1 (File No. 333-259116) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 und

[Signature Page Follows]

September 27, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

As filed with the Securities and Exchange Commission on September 20, 2021.

Table of Contents As filed with the Securities and Exchange Commission on September 20, 2021.

Form of Contribution Agreement.

Exhibit 2.1 CONTRIBUTION AND EXCHANGE AGREEMENT BY AND AMONG OLAPLEX HOLDINGS, INC., PENELOPE GROUP HOLDINGS, L.P., OLAPLEX INTERMEDIATE, INC., THE SOLE MEMBER OF PENELOPE GROUP HOLDINGS GP II, LLC PARTY HERETO AND THE LIMITED PARTNERS OF PENELOPE GROUP HOLDINGS, L.P. PARTY HERETO DATED AS OF [?], 2021 This CONTRIBUTION AND EXCHANGE AGREEMENT (this ?Agreement?), dated as of [?], 2021, is hereby en

Form of Director and Executive Officer Indemnification Agreement.

Exhibit 10.2 INDEMNIFICATION AGREEMENT This Indemnification Agreement (this ?Agreement?) is made and entered into as of [?], 2021, by and among Olaplex Holdings, Inc., a Delaware corporation (the ?Company?), and [NAME OF DIRECTOR/OFFICER] (?Indemnitee?). WHEREAS, in light of the litigation costs and risks to directors and officers resulting from their service to companies, and the desire of the Co

Form of Registration Rights Agreement.

Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT BY AND AMONG OLAPLEX HOLDINGS, INC. AND CERTAIN STOCKHOLDERS DATED AS OF [ ], 2021 TABLE OF CONTENTS ARTICLE I EFFECTIVENESS 1 Section 1.1. Effectiveness. 1 ARTICLE II DEFINITIONS 1 Section 2.1. Definitions. 1 Section 2.2. Other Interpretive Provisions. 5 ARTICLE III REGISTRATION RIGHTS 6 Section 3.1. Demand Registration. 6 Section 3.2. Shelf Registration

Transition and Separation Letter Agreement, dated April 5, 2021, between Olaplex, Inc. and James MacPherson.

Exhibit 10.13 April 5, 2021 James McPherson Dear Jim: The purpose of this letter agreement (this ?Agreement?) is to confirm the terms of the remainder of your employment with Olaplex, Inc. (the ?Company?) and your separation from the Company, as follows: 1. Transition Period and Separation Date. (a) Effective as of the date hereof (the ?Transition Date?) through the date on which your employment t

Form of Notice of Adjustment of Options.

Exhibit 10.14 MEMORANDUM From: [] To: [] Date: September [], 2021 Re: Conversion of Option Awards On September [?], 2021, the board of directors (the ?Board?) of Penelope Holdings Corp., a Delaware corporation, (?Holdings Corp.?) and the Compensation Committee of Penelope Group Holdings GP, LLC (?Holdings GP?) took certain actions with respect to each outstanding option to purchase common stock of

Form of Restricted Stock Unit Agreement (Director) under the Olaplex Holdings, Inc. 2021 Equity Incentive Plan

Exhibit 10.17 Name: [ ] Number of Restricted Stock Units: [ ] Date of Grant: [ ] Vesting Commencement Date: [ ] OLAPLEX HOLDINGS, INC. 2021 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT (DIRECTOR) This agreement (this ?Agreement?) evidences an award (the ?Award?) of Restricted Stock Units (?RSUs?) granted by Olaplex Holdings, Inc., a Delaware corporation (the ?Company?), to the individual

Olaplex Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.15 to the Registrant’s Registration Statement on Form S-1/A, filed on September 20, 2021 (File No. 333- 259116)).

Exhibit 10.15 OLAPLEX HOLDINGS, INC. 2021 EQUITY INCENTIVE PLAN 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines certain terms used in the Plan and includes certain operational rules related to those terms. 2. PURPOSE The Plan has been established to advance the interests of the Company by providing for the grant to Participants of Stock and Stock-based Awards. 3. ADMINISTRA

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant Entity Jurisdiction Subsidiaries of Olaplex Holdings, Inc.1 Olaplex Intermediate, Inc. Olaplex Intermediate II, Inc. Penelope Holdings Corp. Penelope Intermediate Corp. Olaplex, Inc. Olaplex UK Limited Delaware Delaware Delaware Delaware Delaware United Kingdom Subsidiaries of Penelope Group Holdings L.P.2 Penelope Holdings Corp. Penelope Intermediate Co

Form of Underwriting Agreement.

Exhibit 1.1 Olaplex Holdings, Inc. Common Stock Underwriting Agreement [ ? ], 2021 Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC Morgan Stanley & Co. LLC As representatives (the ?Representatives?) of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 101

Form of Non-Statutory Stock Option Agreement (Employee) under the Olaplex Holdings, Inc. 2021 Equity Incentive Plan

Exhibit 10.16 Name: [ ] Number of Shares of Stock subject to the Stock Option: [ ] Exercise Price Per Share: $[ ] Date of Grant: [ ] Vesting Commencement Date: [ ] OLAPLEX HOLDINGS, INC. 2021 EQUITY INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT (EMPLOYEE) This agreement (this ?Agreement?) evidences a stock option granted by Olaplex Holdings, Inc., a Delaware corporation (the ?Company?), to t

Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1/A, filed on September 20, 2021 (File No. 333-259116)).

Exhibit 4.1 Olaplex NUMBER SHARES COMMON STOCK INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 679369 10 8 SPECIMEN - NOT NEGOTIABLE This Certifies That: is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF $0.001 PAR VALUE EACH OF Olaplex Holdings, Inc. transferable on the books of the Corporation by the holder hereof in person or

CONFIDENTIAL TREATMENT REQUESTED BY OLAPLEX HOLDINGS, INC.

Submitted pursuant to a Request for Confidential Treatment Pursuant to 17 C.F.R. 200.83 FOIA Confidential Treatment Request The entity requesting confidential treatment is Olaplex Holdings, Inc. 1187 Coast Village Rd, Suite 1-520 Santa Barbara, CA 93108 Attention: President and Chief Executive Officer Phone: (310) 691-0776 Certain confidential information in this letter has been omitted and provid

* * *

August 27, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F.

First Incremental Amendment to the Credit Agreement, dated December 18, 2020, by and among Olaplex, Inc., Penelope Intermediate Corp., MidCap Financial trust, as the Administrative Agent, Swingline Lender and Issuing Bank, the 2020 Incremental Term Loan Lenders, the 2020 Incremental Revolving Facility Lenders, and the other Lenders party thereto.

Exhibit 10.4 FIRST INCREMENTAL AMENDMENT This FIRST INCREMENTAL AMENDMENT to the Credit Agreement referred to below, dated as of December 18, 2020 (this ?First Amendment?), by and among Olaplex, Inc., a Delaware corporation (the ?Borrower?), Penelope Intermediate Corp., a Delaware corporation (?Holdings?), the 2020 Incremental Term Loan Lenders (as defined below), the 2020 Incremental Revolving Fa

Offer Letter, dated April 28, 2020, by and between Olaplex, Inc. and James MacPherson.

Exhibit 10.12 Olaplex, Inc. April 28, 2020 James MacPherson Dear James: I am pleased to offer you employment with Olaplex, Inc. (the ?Company?) in the position of Chief Financial Officer, reporting directly to the Company?s Chief Executive Officer. If you accept this offer, your first date of employment with the Company will be May 4, 2020. Your initial salary will be at the rate of $400,000.00 pe

Offer Letter, dated January 8, 2020, by and between Olaplex, Inc. and Tiffany Walden.

Exhibit 10.10 Olaplex, Inc. January 8, 2020 Tiffany Walden Dear Tiffany: I am pleased to offer you employment with Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?) in the position of Chief Operating Officer/Chief Legal Officer reporting directly to the Company?s Chief Executive Officer. In connection therewith, the Company will also cause you to become a member of the Board of M

Form of Restated Certificate of Incorporation of Olaplex Holdings, Inc.

Exhibit 3.1 RESTATED CERTIFICATE OF INCORPORATION OF OLAPLEX HOLDINGS, INC. Olaplex Holdings, Inc., a Delaware corporation (the ?Corporation?), hereby certifies that this Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (the ?DGCL?), and that: A. The name of the Corporation is: Olaplex Holdin

Form of Amended and Restated Bylaws of Olaplex Holdings, Inc.

Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF OLAPLEX HOLDINGS, INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of Olaplex Holdings, Inc., a Delaware corporation (the ?Corporation?), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shall be held at t

Termination Protection Agreement, dated January 28, 2020, by and between Olaplex, Inc. and JuE Wong.

Exhibit 10.9 TERMINATION PROTECTION AGREEMENT This TERMINATION PROTECTION AGREEMENT (this ?Agreement?) is made and entered into as of January 28, 2020 by and between Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?) and JuE Wong (the ?Executive?), and is effective as of the Closing Date, as such term is defined in the Purchase Agreement by and among Olaplex LLC, Liqwd, Inc., Chri

Manufacturing Services Agreement, dated January 1, 2020, by and between Olaplex, Inc. and Cosway Company Inc.

Exhibit 10.5 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO OLAPLEX HOLDINGS, INC. IF PUBLICLY DISCLOSED. MANUFACTURING SERVICES AGREEMENT This Manufacturing Services Agreement (?Agreement?) is entered into as of January 1, 2020 (the ?Effective Date?) by and between Olaplex (?Olapl

Penelope Holdings Corp. 2020 Omnibus Equity Incentive Plan.

Exhibit 10.6 Penelope Holdings Corp. 2020 OMNIBUS EQUITY INCENTIVE PLAN Article 1. Establishment & Purpose 1.1 Establishment. Penelope Holdings Corp., a Delaware corporation (the ?Company?), hereby establishes the 2020 Omnibus Equity Incentive Plan (the ?Plan?) as set forth herein. 1.2 Purpose of the Plan. The purpose of the Plan is to attract, retain and motivate the management, employees and cer

Offer Letter, dated January 28, 2020, by and between Olaplex, Inc. and JuE Wong.

Exhibit 10.8 January 28, 2020 JuE Wong Dear JuE: I am pleased to confirm our offer of employment to you as Chief Executive Officer of Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?). This offer is contingent upon (i) the successful closing (the ?Closing?) of the asset purchase transactions contemplated by and among the Company, Olaplex LLC, and LiQWD, Inc. and (ii) your success

Form of Nonqualified Stock Option Award Agreement under the 2020 Plan.

Exhibit 10.7 Penelope Holdings Corp. 2020 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Award Agreement THIS AGREEMENT (this ?Award Agreement?), is made effective as of [Insert Grant Date] (the ?Grant Date?), by and between Penelope Holdings Corp., a Delaware corporation (the ?Company?), and [Insert Employee Name] (the ?Participant?). Capitalized terms used but not otherwise defined here

Termination Protection Agreement, dated January 8, 2020, by and between Olaplex, Inc. and Tiffany Walden.

Exhibit 10.11 Execution Version TERMINATION PROTECTION AGREEMENT This TERMINATION PROTECTION AGREEMENT (this ?Agreement?) is made and entered into as of January 8, 2020 by and between Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?) and Tiffany M. Walden (the ?Executive?), and is effective as of the Closing Date, as such term is defined in the Purchase Agreement by and among Ola

Form of Income Tax Receivable Agreement.

Exhibit 10.3 FORM OF INCOME TAX RECEIVABLE AGREEMENT Dated as of [ ], 2021 This INCOME TAX RECEIVABLE AGREEMENT (as amended from time to time, this ?Agreement?), dated as of [ ], 2021, is hereby entered into by and among Olaplex Holdings, Inc., a Delaware corporation (the ?Corporation?), the persons listed on Annex A hereto (each a ?TRA Party? and collectively the ?TRA Parties?) and each of the pe

As filed with the Securities and Exchange Commission on August 27, 2021.

S-1 Table of Contents As filed with the Securities and Exchange Commission on August 27, 2021.

As confidentially submitted with the Securities and Exchange Commission on August 6, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confident

Table of Contents As confidentially submitted with the Securities and Exchange Commission on August 6, 2021.

Bracketed and Highlighted Information Subject to Confidential Treatment Request CONFIDENTIAL TREATMENT REQUESTED BY OLAPLEX HOLDINGS, INC. UNDER 17 C.F.R. §200.83 FOR REQUEST NO. 1

Submitted pursuant to a Request for Confidential Treatment Pursuant to 17 C.F.R. 200.83 FOIA Confidential Treatment Request The entity requesting confidential treatment is Olaplex Holdings, Inc. 1187 Coast Village Rd, Suite 1-520 Santa Barbara, CA 93108 Attention: Chief Financial Officer Phone: (310) 691-0776 Certain confidential information in this letter has been omitted and provided separately

As confidentially submitted with the Securities and Exchange Commission on June 25, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidenti

Table of Contents As confidentially submitted with the Securities and Exchange Commission on June 25, 2021.

Penelope Holdings Corp. 2020 OMNIBUS EQUITY INCENTIVE PLAN

Exhibit 10.6 Penelope Holdings Corp. 2020 OMNIBUS EQUITY INCENTIVE PLAN Article 1. Establishment & Purpose 1.1 Establishment. Penelope Holdings Corp., a Delaware corporation (the ?Company?), hereby establishes the 2020 Omnibus Equity Incentive Plan (the ?Plan?) as set forth herein. 1.2 Purpose of the Plan. The purpose of the Plan is to attract, retain and motivate the management, employees and cer

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO OLAPLEX HOLDINGS, INC. IF PUBLICLY DISCLOSED. MANUFACTURING SERVICES AGREEMENT

Exhibit 10.5 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO OLAPLEX HOLDINGS, INC. IF PUBLICLY DISCLOSED. MANUFACTURING SERVICES AGREEMENT This Manufacturing Services Agreement (?Agreement?) is entered into as of January 1, 2020 (the ?Effective Date?) by and between Olaplex (?Olapl

FIRST INCREMENTAL AMENDMENT

Exhibit 10.4 FIRST INCREMENTAL AMENDMENT This FIRST INCREMENTAL AMENDMENT to the Credit Agreement referred to below, dated as of December 18, 2020 (this ?First Amendment?), by and among Olaplex, Inc., a Delaware corporation (the ?Borrower?), Penelope Intermediate Corp., a Delaware corporation (?Holdings?), the 2020 Incremental Term Loan Lenders (as defined below), the 2020 Incremental Revolving Fa

TERMINATION PROTECTION AGREEMENT

Exhibit 10.11 Execution Version TERMINATION PROTECTION AGREEMENT This TERMINATION PROTECTION AGREEMENT (this ?Agreement?) is made and entered into as of January 8, 2020 by and between Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?) and Tiffany M. Walden (the ?Executive?), and is effective as of the Closing Date, as such term is defined in the Purchase Agreement by and among Ola

Penelope Holdings Corp. 2020 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Award Agreement

Exhibit 10.7 Penelope Holdings Corp. 2020 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Award Agreement THIS AGREEMENT (this ?Award Agreement?), is made effective as of [Insert Grant Date] (the ?Grant Date?), by and between Penelope Holdings Corp., a Delaware corporation (the ?Company?), and [Insert Employee Name] (the ?Participant?). Capitalized terms used but not otherwise defined here

Olaplex, Inc.

Exhibit 10.12 Olaplex, Inc. April 28, 2020 James MacPherson Dear James: I am pleased to offer you employment with Olaplex, Inc. (the ?Company?) in the position of Chief Financial Officer, reporting directly to the Company?s Chief Executive Officer. If you accept this offer, your first date of employment with the Company will be May 4, 2020. Your initial salary will be at the rate of $400,000.00 pe

Olaplex, Inc.

Exhibit 10.10 Olaplex, Inc. January 8, 2020 Tiffany Walden Dear Tiffany: I am pleased to offer you employment with Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?) in the position of Chief Operating Officer/Chief Legal Officer reporting directly to the Company?s Chief Executive Officer. In connection therewith, the Company will also cause you to become a member of the Board of M

[Signature Page to Offer Letter]

Exhibit 10.8 January 28, 2020 JuE Wong Dear JuE: I am pleased to confirm our offer of employment to you as Chief Executive Officer of Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?). This offer is contingent upon (i) the successful closing (the ?Closing?) of the asset purchase transactions contemplated by and among the Company, Olaplex LLC, and LiQWD, Inc. and (ii) your success

TERMINATION PROTECTION AGREEMENT

Exhibit 10.9 TERMINATION PROTECTION AGREEMENT This TERMINATION PROTECTION AGREEMENT (this ?Agreement?) is made and entered into as of January 28, 2020 by and between Olaplex, Inc. (formerly Penelope Acquisition Corp.) (the ?Company?) and JuE Wong (the ?Executive?), and is effective as of the Closing Date, as such term is defined in the Purchase Agreement by and among Olaplex LLC, Liqwd, Inc., Chri